Trial: 201911131

A Phase I Study of ApoGraft for the Prevention of Acute Graft Versus Host Disease in Haploidentical Hematopoietic Cell Transplant Recipients

Phase

I

Principal Investigator

Xiang, Zhifu

Disease Site

Hodgkin’s Lymphoma; Lymphoid Leukemia; Myeloid and Monocytic Leukemia; Non-Hodgkin’s Lymphoma; Other Hematopoietic

Learn more about this study at: clinicaltrials.gov